BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34611590)

  • 1. Optimal intermittent administration interval of parathyroid hormone 1-34 for bone morphogenetic protein-induced bone formation in a rat spinal fusion model.
    Abe T; Miyazaki M; Ishihara T; Kanezaki S; Tsubouchi Y; Tsumura H
    JOR Spine; 2021 Sep; 4(3):e1168. PubMed ID: 34611590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the effects of intermittent parathyroid hormone (1-34) by bone morphogenetic protein in a rat femoral open fracture model.
    Kanezaki S; Miyazaki M; Ishihara T; Notani N; Abe T; Tsubouchi Y; Kataoka M; Tsumura H
    J Orthop Surg Res; 2019 Nov; 14(1):403. PubMed ID: 31783887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Intermittent Administration of Teriparatide (Parathyroid Hormone 1-34) on Bone Morphogenetic Protein-Induced Bone Formation in a Rat Model of Spinal Fusion.
    Morimoto T; Kaito T; Kashii M; Matsuo Y; Sugiura T; Iwasaki M; Yoshikawa H
    J Bone Joint Surg Am; 2014 Jul; 96(13):e107. PubMed ID: 24990981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of the anabolic and catabolic responses with BMP-2 and zoledronic acid in a rat femoral fracture model.
    Doi Y; Miyazaki M; Yoshiiwa T; Hara K; Kataoka M; Tsumura H
    Bone; 2011 Oct; 49(4):777-82. PubMed ID: 21777711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulation of anabolic and catabolic responses with bone morphogenetic protein and zoledronic acid in a rat spinal fusion model.
    Kodera R; Miyazaki M; Yoshiiwa T; Kawano M; Kaku N; Tsumura H
    Bone; 2014 Jan; 58():26-32. PubMed ID: 24103577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the effects of exfoliated carbon nanofibers using bone morphogenetic protein in a rat spinal fusion model.
    Notani N; Miyazaki M; Toyoda M; Kanezaki S; Ishihara T; Tsumura H
    J Orthop Res; 2018 Nov; 36(11):2892-2900. PubMed ID: 29917272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model.
    Kaito T; Morimoto T; Kanayama S; Otsuru S; Kashii M; Makino T; Kitaguchi K; Furuya M; Chijimatsu R; Ebina K; Yoshikawa H
    Bone Rep; 2016 Dec; 5():173-180. PubMed ID: 28580385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis.
    Lina IA; Puvanesarajah V; Liauw JA; Lo SF; Santiago-Dieppa DR; Hwang L; Mao A; Bydon A; Wolinsky JP; Sciubba DM; Gokaslan Z; Holmes C; Witham TF
    Spine (Phila Pa 1976); 2014 Mar; 39(5):347-55. PubMed ID: 24365898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Wang JC; Kanim LE; Yoo S; Campbell PA; Berk AJ; Lieberman JR
    J Bone Joint Surg Am; 2003 May; 85(5):905-11. PubMed ID: 12728043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment.
    Holmes CA; Ishida W; Elder BD; Lo SL; Chen YA; Kim E; Locke J; Taylor M; Witham TF
    World Neurosurg; 2018 Jul; 115():e366-e374. PubMed ID: 29678698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.
    Valdes M; Moore DC; Palumbo M; Lucas PR; Robertson A; Appel J; Ehrlich MG; Keeping HS
    Spine J; 2007; 7(3):318-25. PubMed ID: 17482115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intermittent PTH (1-34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model.
    Qiu Z; Wei L; Liu J; Sochacki KR; Liu X; Bishop C; Ebraheim M; Yang H
    Osteoporos Int; 2013 Oct; 24(10):2693-700. PubMed ID: 23756875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic retinoic acid receptor γ antagonist (7C)-loaded nanoparticle enhances bone morphogenetic protein-induced bone regeneration in a rat spinal fusion model.
    Tateiwa D; Iwamoto M; Kodama J; Ukon Y; Hirai H; Ikuta M; Kitahara T; Furuichi T; Bun M; Otsuru S; Okada S; Kaito T
    Spine J; 2024 May; 24(5):899-908. PubMed ID: 38092193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model.
    Morimoto T; Kaito T; Matsuo Y; Sugiura T; Kashii M; Makino T; Iwasaki M; Yoshikawa H
    Spine J; 2015 Jun; 15(6):1379-90. PubMed ID: 25733023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The osteoinductive properties of Nell-1 in a rat spinal fusion model.
    Lu SS; Zhang X; Soo C; Hsu T; Napoli A; Aghaloo T; Wu BM; Tsou P; Ting K; Wang JC
    Spine J; 2007; 7(1):50-60. PubMed ID: 17197333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovariectomy-Induced Osteoporosis Does Not Impact Fusion Rates in a Recombinant Human Bone Morphogenetic Protein-2-Dependent Rat Posterolateral Arthrodesis Model.
    Ghodasra JH; Nickoli MS; Hashmi SZ; Nelson JT; Mendoza M; Nicolas JD; Bellary SS; Sonn K; Ashtekar A; Park CJ; Babu J; Yun C; Ghosh A; Kannan A; Stock SR; Hsu WK; Hsu EL
    Global Spine J; 2016 Feb; 6(1):60-8. PubMed ID: 26835203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats.
    Miyazaki M; Sugiyama O; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Virk MS; Lieberman JR; Wang JC
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1410-7. PubMed ID: 18475244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis.
    Sugiura T; Kashii M; Matsuo Y; Morimoto T; Honda H; Kaito T; Iwasaki M; Yoshikawa H
    Spine J; 2015 Feb; 15(2):298-306. PubMed ID: 25110274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.